Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression

Autor: Eduard Maron, Triin Eller, Veiko Vasar, Anu Tammiste, David J. Nutt, Andres Metspalu, Kristi Kallassalu
Rok vydání: 2009
Předmět:
Zdroj: European Neuropsychopharmacology. 19:451-456
ISSN: 0924-977X
DOI: 10.1016/j.euroneuro.2009.01.010
Popis: Several studies and meta-analyses have implicated a polymorphism in the promoter region of the serotonin transporter (5-HTT) gene, 5-HTTLPR in treatment outcomes of selective serotonin re-uptake inhibitors in patients with major depression. In this study we investigated the impact of 5-HTTLPR and a functional SNP rs25531 on the treatment outcomes to escitalopram in depressive patients. The study sample consisted of 135 outpatients with major depressive disorder (mean age 31.1+/-11.6 years, 68% females) treated with escitalopram 10-20 mg/day for 12 weeks. There were no significant associations between 5-HTT promoter region polymorphisms and response rate or mean change of depressive symptoms during escitalopram treatment. However we showed that patients carrying S allele of 5-HTTLPR may have increased risk for some side effects, including headache, induced by escitalopram medication.
Databáze: OpenAIRE